-+ 0.00%
-+ 0.00%
-+ 0.00%

STOKE THERAPEUTICS AND BIOGEN ANNOUNCE PRESENTATIONS OF CLINICAL DATA FROM STUDIES OF ZOREVUNERSEN FOR THE POTENTIAL TREATMENT OF DRAVET SYNDROME AT THE 36TH INTERNATIONAL EPILEPSY CONGRESS

Reuters·08/25/2025 11:00:00

Please log in to view news